Find Clinical Trials by University in the United Kingdom

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : United Kingdom

Top of Directory » All Categories » by University » United Kingdom



  • Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

    Condition:   Inflammatory Bowel Disease
    Interventions:   Drug: Monofer;   Drug: Iron Sulphate
    Sponsors:   Pharmacosmos A/S;   Max Neeman International
    Recruiting - verified November 2009
  • Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

    Condition:   Vaccine
    Intervention:   Biological: CoVaccine HT
    Sponsor:   Protherics
    Not yet recruiting - verified November 2009
  • Adaprev in Digital Flexor Tendon Repair

    Condition:   Tendon Injuries
    Intervention:   Device: Adaprev
    Sponsor:   Renovo
    Recruiting - verified November 2009
  • BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

    Condition:   Healthy
    Interventions:   Drug: BIIB014;   Drug: Placebo
    Sponsor:   Biogen Idec
    Recruiting - verified November 2009
  • Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Fosinopril;   Other: lactose
    Sponsors:   Imperial College London;   Medical Research Council
    Recruiting - verified November 2009
  • Outcome in Patients Having Heart Failure and Treated as Per Guidelines

    Condition:   Heart Failure
    Intervention:  
    Sponsor:   County Durham and Darlington NHS Foundation Trust
    Not yet recruiting - verified November 2009
  • Early Percutaneous Coronary Intervention (PCI) After Fibrinolysis Versus Standard Therapy in ST Segment Elevation Myocardial Infarction (STEMI) Patients

    Condition:   Myocardial Infarction
    Intervention:  
    Sponsor:   Royal Brompton & Harefield NHS Foundation Trust
    Recruiting - verified November 2009
  • Efficacy, Safety, Tolerability and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

    Condition:   Asthma
    Interventions:   Drug: QAB149 placebo;   Drug: QAB149;   Drug: QAB149;   Drug: QAB149
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009
  • Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

    Conditions:   QTc Evaluation;   Electrocardiography
    Interventions:   Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Placebo
    Sponsor:   Bayer
    Not yet recruiting - verified November 2009
  • An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

    Condition:   Hepatitis B, Chronic
    Intervention:  
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009
  • Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

    Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009
  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009
  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009
  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Study of Ataluren (PTC124®) in Nonambulatory Patients With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)

    Conditions:   Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
    Intervention:   Drug: Ataluren (PTC124)
    Sponsors:   PTC Therapeutics;   Genzyme
    Not yet recruiting - verified November 2009
  • Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

    Condition:   Lymphoma, Large-Cell, Diffuse
    Interventions:   Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • A Clinical Investigation to Evaluate Negative Pressure Wound Therapy (NPWT) System in the Treatment of Diabetic Foot Ulcers (DFUs) Including Post Amputation Wounds Associated With Diabetes

    Conditions:   Diabetes;   Foot Ulcers
    Intervention:   Procedure: AvanceTM NPWT System
    Sponsor:   Molnlycke Health Care AB
    Not yet recruiting - verified November 2009
  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

    Condition:   Macular Degeneration
    Interventions:   Device: Epimacular Brachytherapy;   Drug: Ranibizumab
    Sponsors:   King's College Hospital NHS Trust;   NeoVista
    Not yet recruiting - verified November 2009
  • Patient Satisfaction in the Critical Care Unit: A Qualitative Phenomenological Study

    Condition:   Patient Satisfaction in the Critical Care Unit
    Intervention:  
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified November 2009
  • Rehabilitation of Early Stroke Patients Using an AFO: an RCT

    Conditions:   Stroke;   Hemiplegia
    Intervention:   Other: Solid Ankle Foot Orthosis
    Sponsor:   University of Strathclyde
    Not yet recruiting - verified November 2009
  • Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer

    Condition:   Prostate Cancer
    Interventions:   Other: Imaging Investigations (not radiation);   Other: Other
    Sponsors:   Royal Marsden NHS Foundation Trust;   Institute of Cancer Research, United Kingdom
    Recruiting - verified November 2009
  • Adherence to Self-care Regimens for Young People With Food Allergy

    Condition:   Food Allergy
    Intervention:  
    Sponsors:   Brighton & Sussex Medical School;   Brighton and Sussex University Hospitals NHS Trust;   Guys & St Thomas' Foundation NHS Trust
    Not yet recruiting - verified October 2009
  • Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN1250;   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Not yet recruiting - verified September 2009
  • CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis

    Conditions:   Neonatal Sepsis;   Enterocolitis, Necrotizing
    Intervention:  
    Sponsor:   Newcastle-upon-Tyne Hospitals NHS Trust
    Recruiting - verified October 2009
  • Micronutrient Supplementation in Patients With Heart Failure

    Condition:   Heart Failure
    Interventions:   Drug: Placebo;   Drug: Forceval plus 50 micrograms Vitamin D3
    Sponsor:   Belfast Health and Social Care Trust
    Recruiting - verified October 2009
  • A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery

    Conditions:   Haemodialysis;   Surgery
    Intervention:   Procedure: Arterial and venous duplex ultrasound examination
    Sponsor:   University of Hull
    Not yet recruiting - verified October 2009
  • Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

    Condition:   Advanced Solid Tumors
    Intervention:   Drug: panobinostat (LBH589)
    Sponsor:   Novartis Pharmaceuticals
    Not yet recruiting - verified November 2009
  • Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults

    Condition:   Metabolic Syndrome X
    Interventions:   Dietary Supplement: Bimuno;   Dietary Supplement: Maltodextrin
    Sponsors:   Clasado;   University of Reading
    Recruiting - verified October 2009
  • Phase IIa Study of MP4OX in Hemorrhagic Shock Patients With Lactic Acidosis

    Conditions:   Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
    Interventions:   Drug: MP4OX;   Drug: MP4OX;   Drug: Ringer's Lactate solution
    Sponsor:   Sangart
    Not yet recruiting - verified November 2009
  • A Study of the Safety and Effectiveness of Two New Malaria Vaccines

    Condition:   Malaria
    Interventions:   Biological: AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine;   Biological: AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge
    Sponsor:   University of Oxford
    Not yet recruiting - verified October 2009
  • Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer

    Condition:   Non-small Cell Lung Cancer
    Interventions:   Other: Arterial puncture;   Other: Venepuncture;   Procedure: General anaesthetic;   Procedure: Inpatient stays;   Other: Walking test;   Other: Spirometry & flow volume loop assessment;   Other: Biopsy material
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified October 2009
  • Novel Prognostic Markers in Renal Cancer

    Condition:   Renal Cell Carcinoma
    Intervention:  
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified October 2009
  • Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis

    Conditions:   Psychosis;   Schizophrenia;   Bipolar Disorder;   Schizo-affective Disorder
    Intervention:   Other: Acceptance and Commitment Therapy
    Sponsors:   University of Glasgow;   Greater Glasgow and Clyde NHS
    Not yet recruiting - verified October 2009
  • The Identification of Novel Prognostic Markers in Melanoma

    Condition:   Malignant Melanoma
    Intervention:  
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified October 2009
  • SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)

    Condition:   Breast Cancer
    Intervention:   Radiation: Imaging investigations (with radiation)
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified October 2009
  • Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

    Condition:   Asthma
    Intervention:   Biological: Mepolizumab (treatment) - Severe asthma
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

    Condition:   Actinic Keratosis
    Intervention:   Procedure: Metvix PDT
    Sponsor:   Galderma
    Recruiting - verified November 2009
  • Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009
  • Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

    Condition:   Carotid Atherosclerosis
    Intervention:   Other: PET-CT with CuATSM
    Sponsors:   King's College London;   Guy's and St Thomas' NHS Foundation Trust
    Not yet recruiting - verified October 2009
  • The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen

    Condition:   Allergic Asthma
    Interventions:   Drug: AZD8848;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified October 2009
  • LEO 27847 - A Study in Healthy Male Subjects

    Condition:   Healthy
    Intervention:   Drug: LEO 27847
    Sponsor:   LEO Pharma
    Recruiting - verified November 2009
  • Adaptive Planning in Bladder Cancer

    Condition:   Bladder Cancer
    Interventions:   Other: Adaptive-Planning Organ Localisation (A-POLO) (Planning CT scan);   Other: Cone beam CT acquisition
    Sponsors:   Royal Marsden NHS Foundation Trust;   Institute of Cancer Research, United Kingdom
    Recruiting - verified October 2009
  • Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: exenatide once weekly;   Drug: insulin detemir
    Sponsors:   Amylin Pharmaceuticals, Inc.;   Eli Lilly and Company
    Recruiting - verified November 2009
  • Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

    Condition:   H1N1 Influenza Vaccination
    Intervention:   Other: Safety follow up
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

    Condition:   Acromegaly
    Intervention:   Drug: BIM 23A760
    Sponsor:   Ipsen
    Recruiting - verified November 2009
  • Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

    Condition:   Carcinoma, Hepatocellular
    Interventions:   Drug: BIBF 1120;   Drug: Sorafenib
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009
  • An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

    Condition:   Renal Cell Carcinoma
    Interventions:   Drug: Bevacizumab;   Drug: Pazopanib 2 week;   Drug: Pazopanib 3 week
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials